What is the definition and pathophysiology of respiratory failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition and Pathophysiology of Respiratory Failure

Respiratory failure is defined as the inability of the respiratory system to maintain adequate gas exchange, characterized by PaO₂ <8 kPa (60 mmHg) with or without PaCO₂ >6 kPa (45 mmHg), resulting from failure of oxygenation, ventilation, or both. 1, 2

Core Definition

Respiratory failure represents a breakdown in the cardiopulmonary system's ability to maintain adequate oxygen delivery to tissues and/or adequate carbon dioxide removal from tissues. 3, 4 The condition is diagnosed when arterial blood gas analysis reveals:

  • PaO₂ <60 mmHg (8 kPa) while breathing room air 1, 2, 5
  • With or without elevated PaCO₂ depending on the type 2, 6

Classification System

Type 1 (Hypoxemic) Respiratory Failure

  • Defined by PaO₂ <8 kPa (60 mmHg) with normal or low PaCO₂ (≤6 kPa or 45 mmHg) 1, 2
  • Results from failure to maintain adequate oxygenation despite normal or increased ventilatory effort 1
  • Hypoxemia is the dominant feature with preserved ventilatory capacity 6

Type 2 (Hypercapnic) Respiratory Failure

  • Defined by PaO₂ <8 kPa (60 mmHg) AND PaCO₂ >6 kPa (45 mmHg) 1, 2
  • Represents failure of the ventilatory pump to eliminate CO₂ produced by metabolism 1, 2
  • Both hypoxemia and hypercapnia are present 2

Pathophysiological Mechanisms

Type 1 Respiratory Failure Mechanisms

Ventilation-perfusion (V/Q) mismatch is the primary mechanism, where blood flows through poorly ventilated lung regions, preventing adequate oxygenation. 1, 2, 6

Intrapulmonary shunting occurs when blood bypasses ventilated alveoli entirely, flowing through completely unventilated or fluid-filled lung units—this does not respond to supplemental oxygen. 1

Diffusion impairment results from thickened alveolar-capillary membranes, limiting oxygen transfer across the interface. 1, 6

Common clinical causes include:

  • ARDS: Bilateral infiltrates with increased pulmonary capillary permeability, classified as mild (PaO₂/FiO₂ 200-300 mmHg), moderate (100-200 mmHg), or severe (≤100 mmHg) 7, 1
  • Pneumonia: Creates consolidated lung regions with shunt physiology 1
  • Pulmonary edema: Fills alveoli with fluid from increased vascular permeability or hydrostatic pressure 7, 1

Type 2 Respiratory Failure Mechanisms

Alveolar hypoventilation is the fundamental mechanism, where minute ventilation is insufficient relative to CO₂ production. 1, 2, 6

Increased mechanical workload develops from:

  • Increased airway resistance requiring greater inspiratory effort 1, 8
  • Dynamic hyperinflation with intrinsic PEEP (PEEPi) trapping air and flattening the diaphragm 1, 8
  • Inspiratory muscle dysfunction from fatigue or weakness 1, 8

Increased dead space ventilation occurs when ventilated alveoli are not perfused, wasting ventilatory effort. 8 This shifts breathing to a rapid shallow pattern (high respiratory rate, low tidal volume) that increases the dead space/tidal volume ratio of each breath. 8

Common clinical causes include:

  • COPD exacerbations: Airflow obstruction with air trapping and V/Q mismatch 7, 1, 8
  • Neuromuscular disorders: Respiratory muscle weakness preventing adequate ventilation 7, 1
  • Chest wall deformities: Restrictive defects limiting lung expansion 1

Sepsis-Related Respiratory Dysfunction

Sepsis creates a spectrum of respiratory abnormalities from subclinical changes to full ARDS. 7, 1 Multiple factors increase work of breathing:

  • Increased dead space ventilation from vascular bed obliteration 7, 1
  • Respiratory muscle dysfunction 1
  • Decreased thoracic compliance from edema 1
  • Bronchoconstriction 1

Both increased physiological dead space and intrapulmonary shunting drive tachypnea and elevated minute ventilation. 1

Clinical Course and Natural History

ARDS Progression

The natural history is dominated by the inciting event rather than lung injury itself. 7 Death from refractory respiratory failure is unusual; the most common cause of death is multiple organ failure or recurrent sepsis. 7

In patients resolving rapidly (10-14 days):

  • Minute ventilation and dead-space ventilation decrease with improving oxygenation 7
  • The lung withstands higher forces in early ARDS without evident barotrauma 7

In severe ARDS with fibrosis development:

  • Minute ventilatory requirements remain high despite improving oxygenation 7
  • Progressive vascular bed obliteration increases dead-space ventilation 7
  • Mortality was historically 60-70% but has declined to approximately 40% 7

Acute vs. Chronic Respiratory Failure

Acute respiratory failure develops suddenly with rapid arterial blood gas deterioration. 1

Chronic respiratory failure develops gradually with compensatory mechanisms like renal bicarbonate retention buffering the acidosis. 1

Acute-on-chronic respiratory failure presents unique challenges due to altered baseline physiology and limited physiological reserve. 1

Critical Diagnostic Pitfalls

Standard chest radiographs are poor predictors of oxygenation defect severity or clinical outcome. 7, 1 Classic ARDS findings may be asymmetric, patchy, or focal rather than diffuse and bilateral. 7, 1

Clinical recognition of hypoxemia is unreliable—continuous pulse oximetry is essential, though it may be unreliable with poor peripheral perfusion, carbon monoxide poisoning, or methemoglobinemia. 7

Administering high-flow oxygen without monitoring CO₂ can precipitate CO₂ narcosis and respiratory arrest in Type 2 respiratory failure. 1 Controlled oxygen with target saturation 88-92% is mandatory. 7, 1

References

Guideline

Respiratory Failure Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Respiratory Failure Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathophysiology of acute respiratory failure.

Clinics in chest medicine, 1994

Research

The pathogenesis of respiratory failure: an overview.

Respiratory care clinics of North America, 2000

Research

Hyperoxia in the management of respiratory failure: A literature review.

Annals of medicine and surgery (2012), 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Respiratory failure in chronic obstructive pulmonary disease.

The European respiratory journal. Supplement, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.